CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,196 enrolled
Drug / intervention
Integrated Stroke Practice Unit +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04000971
NCT04000971N/ACompleted

C3FIT (Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Care): A Randomized Trial for Stroke

Vanderbilt University Medical Center·interventional·Posted Jun 27, 2019·Updated May 15, 2026

In Brief

A clinical study evaluating Integrated Stroke Practice Unit and Comprehensive or Primary Stroke Center for Stroke and 5 related conditions. Completed, enrolled 1,196 participants across 21 sites.

Detailed Summary

Stroke is the 5th leading cause of death and the leading cause of adult disability in the United States (US). Stroke is a complex disease with multiple interacting risk factors (including genetic, high blood pressure and cholesterol, and lifestyle factors like smoking, diet, and exercise) that lead to initial and recurrent stroke. Up to 90% of stroke survivors have some functional deficit that impacts both physical and mental health.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 27, 2019
Enrollment StartFeb 25, 2020
Primary CompletionSep 30, 2024
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 7.0 years ago

Interventions

Integrated Stroke Practice Unitother

Care teams will follow patients in their home or rehabilitation/skilled nursing facility monthly for 12 visits to assess recovery, manage risk factors, and increase understanding and build positive behavior change for patients and caregivers. Primary and secondary outcomes will be assessed at 3, 6, and 12 months.

Comprehensive or Primary Stroke Centerother

Primary and secondary outcomes will be assessed at 3, 6, and 12 months.